Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Ovarian Neoplasms |
Free Subscription
1 BMC Cancer |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Ovarian Neoplasms is free of charge.
APOC1 is a prognostic biomarker associated with M2 macrophages in ovarian cancer.
BMC Cancer. 2024;24:364.
PubMed
Abstract available
NRG-GY012: Randomized phase 2 study comparing olaparib, cediranib, and the
combination of cediranib/olaparib in women with recurrent, persistent, or
metastatic endometrial cancer.
Cancer. 2023 Dec 21. doi: 10.1002/cncr.35151.
PubMed
Abstract available
Demographic, clinical, and sociocognitive determinants related to physical
activity and dietary intake in patients with ovarian cancer: A cross-sectional
study.
Gynecol Oncol. 2024;183:39-46.
PubMed
Abstract available
Preclinical efficacy of RAF/MEK clamp avutometinib in combination with FAK
inhibition in low grade serous ovarian cancer.
Gynecol Oncol. 2024 Feb 9:S0090-8258(24)00043.
PubMed
Abstract available
Mainstreaming in parallel with ovarian cancer tumor testing to improve genetic
testing uptake.
Gynecol Oncol. 2024 Mar 14:S0090-8258(24)00144.
PubMed
Abstract available
Letter re: Ban et al., A personalized probabilistic approach to ovarian cancer
diagnostics.
Gynecol Oncol. 2024 Mar 15:S0090-8258(24)00155.
PubMed
Nomograms for predicting overall survival and cancer-specific survival of
endometrioid ovarian carcinoma: A retrospective cohort study from the SEER
database.
Int J Gynaecol Obstet. 2023 Nov 27. doi: 10.1002/ijgo.15263.
PubMed
Abstract available
Extreme Case of Surgical Port Metastasis in Ovarian Cancer.
Oncology (Williston Park). 2024;38:110-114.
PubMed
Abstract available
Thank you for your interest in scientific medicine.